Andrew Burgess - Concepedia

Author

Andrew Burgess

Garvan Institute of Medical Research ORCID

Also Known As

, A Burgess, A. Burgess, A. J. Burgess, A.J. Burgess, ANDREW BURGESS, ANDREW J. BURGESS, Andrew Burgess, Andrew J. Burgess, Burgess, Andrew

120

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Garvan Institute of Medical Research The University of Sydney The Kinghorn Cancer Centre St Vincent's Clinic The University of Queensland

About

Andrew Burgess is an author at Garvan Institute of Medical Research specializing in medicine, cell biology, and cell cycle.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1.4K
2	Cell Biology	16	22	1.4K
3	Natural Sciences	4	4	196
4	Health Sciences	1	1	12
5	Social Sciences	1	1	10

Andrew Burgess

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Partial inhibition of Cdk1 in G<sub>2</sub>phase overrides the SAC and decouples mitotic events Rachael A. McCloy, Samuel Rogers, C. Elizabeth Caldon, Cell Cycle	2014	870
Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2/PP2A balance Andrew Burgess, Suzanne Vigneron, Estelle Brioudes, Proceedings of the National Academy of Sciences	2010	686
The Substrate of Greatwall Kinase, Arpp19, Controls Mitosis by Inhibiting Protein Phosphatase 2A Aicha Gharbi-Ayachi, Jean‐Claude Labbé, Andrew Burgess, Science	2010	425
Histone Deacetylase Inhibitors Trigger a G2 Checkpoint in Normal Cells That Is Defective in Tumor Cells Ling Qiu, Andrew Burgess, David P. Fairlie, Molecular Biology of the Cell Histone ModificationsChemoprevention StrategyYeast G2 CheckpointTumor CellsNormal Cells That	2000	250
Greatwall maintains mitosis through regulation of PP2A Suzanne Vigneron, Estelle Brioudes, Andrew Burgess, The EMBO Journal Cell DivisionCytoskeletonCellular StructureCellular BiochemistryMedicine	2009	205
Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints Robyn Warrener, Heather Beamish, Andrew Burgess, The FASEB Journal Tumor BiologyCell Cycle CheckpointsOncologyCell DivisionMedicine	2003	147
Up-Regulation of p21WAF1/CIP1 by Histone Deacetylase Inhibitors Reduces Their Cytotoxicity Andrew Burgess, Sandra Pavey, Robyn Warrener, Molecular Pharmacology	2001	136
Histone deacetylase inhibitors specifically kill nonproliferating tumour cells Andrew Burgess, Astrid A. Ruefli, Heather Beamish, Oncogene Tumor BiologyMedicineHistone Deacetylase InhibitorsAnti-cancer AgentTumor Suppressor	2004	128
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer Angela Chou, Danielle Froio, Adnan Nagrial, Gut	2017	117
Characterization of the Mechanisms Controlling Greatwall Activity Suzanne Vigneron, Aicha Gharbi-Ayachi, Anne‐Aurélie Raymond, Molecular and Cellular Biology Unique Agc KinaseMolecular RegulationNext-generation FirewallAgc FamilyMolecular Biology	2011	84

Page 1